Viewing data from:

MELOXICAM

ANDA

MELOXICAM | A209487 | LUPIN LTD

2 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-10-21 | 2 NDCs

Highest NADAC/Unit

$10.76

per ea

Lowest NADAC/Unit

$8.28

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
68180018906MELOXICAM 10 MG CAPSULE	$10.76	EA	Generic	—	2026-10-21
68180018806MELOXICAM 5 MG CAPSULE	$8.28	EA	Generic	—	2026-10-21

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain14 active DMFs9 inactive

14 active API suppliers hold Drug Master Files for this ingredient.

BIDACHEM SPAMELOXICAM

DMF 138461998

ARCH PHARMALABS LTDMELOXICAM USP

DMF 159262002

UNICHEM LABORATORIES LTDMELOXICAM USP

DMF 161892002

CIPLA LTDMELOXICAM USP

DMF 171482004

ANONIMA MATERIE SINTETICHE AND AFFINI (AMSA) SPAMELOXICAM

DMF 172382004

ZYDUS LIFESCIENCES LTDMELOXICAM USP

DMF 173582004

UNIMARK REMEDIES LTDMELOXICAM USP

DMF 182862005

SWATI SPENTOSE PRIVATE LTDMELOXICAM

DMF 188372005

APITORIA PHARMA PRIVATE LTDMELOXICAM USP

DMF 189212005

QUIMICA SINTETICA SAMELOXICAM

DMF 189842005

DERIVADOS QUIMICOS SAUMELOXICAM

DMF 242052010

SHANDONG XINHUA PHARMACEUTICAL CO LTDMELOXICAM

DMF 244762010

IPCA LABORATORIES LTDMELOXICAM USP

DMF 375672022

APEX HEALTHCARE LTDMELOXICAM USP

DMF 399112024

BOEHRINGER INGELHEIM PHARMA GMBH AND CO KGInactiveMELOXICAM JETMILLED

DMF 144301999

ESTEVE QUIMICA SAInactiveMELOXICAM

DMF 166862003

DR REDDYS LABORATORIES LTDInactiveMELOXICAM

DMF 173662004

UNION QUIMICO FARMACEUTICA SA (UQUIFA SA)InactiveMELOXICAM

DMF 182552005

ALKERMES INCInactiveMELOXICAM NANOCRYSTAL® TABLETS

DMF 188052005

CADILA PHARMACEUTICALS LTDInactiveMELOXICAM

DMF 192162006

SICHUAN SANCHINE SUNNYHOPE PHARMACEUTICAL CO LTDInactiveMELOXICAM USP (DRUG SUBSTANCE, NON-STERILE)

DMF 219482008

IROKO PHARMACEUTICALS LLCInactiveMELOXICAM SOLUMATRIX® CAPSULES

DMF 255082011

MICRO LABS LTD INDIAInactiveMELOXICAM USP

DMF 257852012

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Aug 21, 2020	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (2)

Sort:

#001 — 5MG

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Jun 1, 2020

No patent or exclusivity listings for this strength.

#002 — 10MG

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Jun 1, 2020